SDIX LLC:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:SDIX LLC - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C11426
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SDIX LLC (SDIX), a subsidiary of OriGene Technologies Inc, is an immuno-solutions company that develops antibody-based solutions. The company provides IVD solutions and premade antibiotics, among others. Its IVD solutions provide co-development of analyte-specific reagents, diagnostic menu expansion clinical assays, and custom formulation of IVD reagents, large scale production and bioprocessing, among others. SDIX’s cell machinery offers presentation of the epitopes in the native conformation, thus yielding highly reactive antibodies to the native structure of the protein. The company also offers antibody development, antibody production and services and assay development, among others. It serves IVD, anatomic pathology, biotechnology and pharmaceutical markets. SDIX is headquartered in Newark, Delaware, the US.

SDIX LLC – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SDIX LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
SDIX LLC, Medical Equipment Deals By Type, 2012 to YTD 2018 6
SDIX LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
SDIX LLC, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
SDIX LLC, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
SDIX LLC, Medical Equipment, Deal Details 10
Partnerships 10
SDIX Enters Into Licensing Agreement With BD Diagnostic 10
Asset Transactions 11
Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For US$16 Million 11
Romer Labs Completes Acquisition Of Food Safety And GMO Business Of Strategic Diagnostics For US$13.5 Million 13
SDIX LLC – Key Competitors 14
SDIX LLC – Key Employees 15
SDIX LLC – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
SDIX LLC, Medical Equipment, Key Facts 2
SDIX LLC, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
SDIX LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
SDIX LLC, Medical Equipment Deals By Type, 2012 to YTD 2018 6
SDIX LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
SDIX LLC, Deals By Market, 2012 to YTD 2018 8
SDIX LLC, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
SDIX Enters Into Licensing Agreement With BD Diagnostic 10
Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For US$16 Million 11
Romer Labs Completes Acquisition Of Food Safety And GMO Business Of Strategic Diagnostics For US$13.5 Million 13
SDIX LLC, Key Competitors 14
SDIX LLC, Key Employees 15

List of Figures
SDIX LLC, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
SDIX LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
SDIX LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
SDIX LLC, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
SDIX LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
SDIX LLC, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
SDIX LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
SDIX LLC, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[SDIX LLC:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Edison International (EIX):電力:M&Aディール及び事業提携情報
    Summary Edison International (Edison) is an energy holding company. The company generates and distributes electric power; and invests in energy services and technologies, including renewable power, through its subsidiaries. It develops solar products and carries out commercial rooftop installation o …
  • Mediobanca Private Banking:企業の戦略・SWOT・財務情報
    Mediobanca Private Banking - Strategy, SWOT and Corporate Finance Report Summary Mediobanca Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Voyager Therapeutics Inc (VYGR):企業の財務・戦略的SWOT分析
    Summary Voyager Therapeutics Inc (Voyager) is a clinical-stage gene therapy company that develops treatments for patients suffering from severe neurological diseases. The company provides treatment for adeno-associated virus gene therapy field by selecting, designing and manufacturing vectors. Its c …
  • Cisco Systems, Inc (CSCO):企業の財務・戦略的SWOT分析
    Cisco Systems, Inc (CSCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Zirax Ltd:企業の戦略的SWOT分析
    Zirax Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Asian Hotels (North) Limited:企業の戦略・SWOT・財務情報
    Asian Hotels (North) Limited - Strategy, SWOT and Corporate Finance Report Summary Asian Hotels (North) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Sienna Biopharmaceuticals Inc (SNNA)-医療機器分野:企業M&A・提携分析
    Summary Sienna Biopharmaceuticals Inc (Sienna Biopharmaceuticals) is a biopharmaceutical company that develops innovation therapies for inflammatory skin conditions and aesthetic conditions. It offers topical by design or low systemic exposure technology platform for local treatment Photoparticle th …
  • Bilcare Ltd (526853):企業の財務・戦略的SWOT分析
    Bilcare Ltd (526853) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Larsen & Toubro Ltd (LT):企業の財務・戦略的SWOT分析
    Larsen & Toubro Ltd (LT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • DTE Energy Co (DTE):企業の財務・戦略的SWOT分析
    DTE Energy Co (DTE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Banco Comercial Portugues S.A:企業のM&A・事業提携・投資動向
    Banco Comercial Portugues S.A - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Banco Comercial Portugues S.A Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Banque Cantonale Vaudoise (Private Banking):企業の戦略・SWOT・財務情報
    Banque Cantonale Vaudoise (Private Banking) - Strategy, SWOT and Corporate Finance Report Summary Banque Cantonale Vaudoise (Private Banking) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Transcontinental Inc. (TCL.A):企業の財務・戦略的SWOT分析
    Transcontinental Inc. (TCL.A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Tarsa Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Tarsa Therapeutics Inc (Tarsa) develops therapies for the treatment and prevention of osteoporosis and other bone related diseases. The company develops TBRIA, an oral formulation of calcitonin, a peptide hormone that inhibits bone resorption, which is used for the treatment of postmenopausa …
  • Blue Cross and Blue Shield of Florida Inc:企業の戦略的SWOT分析
    Blue Cross and Blue Shield of Florida Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Banco Pan SA (BPAN4):企業の財務・戦略的SWOT分析
    Banco Pan SA (BPAN4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Air Water Inc (4088):企業の財務・戦略的SWOT分析
    Air Water Inc (4088) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • MMRGlobal Inc (MMRF)-医療機器分野:企業M&A・提携分析
    Summary MMRGlobal Inc (MMRGlobal), formerly MMR Information Systems, Inc., is a personal health records company, which provides Personal Health Record (PHR) products and electronic safe deposit box storage solutions. It offers a wide range of secure, online products that helps consumers and professi …
  • Mauna Kea Technologies SAS (MKEA):製薬・医療:M&Aディール及び事業提携情報
    Summary Mauna Kea Technologies SAS (MKT) is an endomicroscopy device manufacturer. The company develops, manufactures and distributes tools to visualize and detect cellular abnormalities during endoscopic procedures. It provides confocal laser endomicroscopy platform. MKT’s cellvizio is an endomicro …
  • LIG Nex1 Co., Ltd.:企業の戦略・SWOT・財務情報
    LIG Nex1 Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary LIG Nex1 Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆